Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

By L. Galluzzi, Juliette Humeau, A. Buqué, L. Zitvogel, Guido Kroemer. Nature Reviews Clinical Oncology, 2020

1,112 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/36db5bb1ac12c1b3d769fe6b865a19ada61853d8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Kongming Wu
2. Ming Yi
3. Xiaoli Zheng
4. Mengke Niu
5. Shuangli Zhu
6. H. Ge

Citations in the corpus

• Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022, background): “Immunogenic cell death is featured with some upregulated damage-associated molecular patterns (DAMPs) such as the secretion of IFN-I, the exposure of endoplasmic reticulum proteins especially calreticulin (CRT, an eat-me signal) on cell membrane, the leak of ATP (a findme signal), and the release of”